Aktiesnakken — Oktober 2010
-
Har forresten fundet 3-5 eksempler på at USPTO godkender patenter indenfor 1-3 måneder efter response
-
10 nov er quiet period, og regnskab d. 24 nov
-
-
der begynder at komme flere og flere indikationer for NGAL http://onlinelibrary.wiley.com/doi/10.1002/ijc.22352/full
-
Unfortunately, there is currently no cost effective screening test.1 The identification of serum biomarkers suitable for early-stage detection has the potential to enormously improve the clinical outcome.
-
Bioporto - nu kommer rykket op snart...
-
støder på den oftere og oftere, at NGAL linkes sammen med canser, hjernesvulster, og lungepatienter osv
-
Vi skal op og teste 8 kr. i dag..
-
og det fortræffelige er, at det ikke kun er en cut off der skal måles, den skal ganges og divideres med alder, køn og race osv
-
så jeg ser muligheder for at sælge NGAL testen til en del andre indikationer også..
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind